Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Promoter Selling

Ajanta Pharma Promoter Selling

Ravi Agrawal Trust, a promoter of Ajanta Pharma, sold 34,50,000 shares (2.76%) via the open market. This transaction reduces the promoter trust's stake to 10.24%.

Source

BSE filing, NSE: AJANTPHARM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Ajanta Pharma Ltd: key numbers

Share price
₹3,459.70
Market cap
₹43,232 Cr
Revenue (annual)
₹5,453 Cr
Net profit (annual)
₹1,056 Cr
P/E (TTM)
38.1×Sector 48.7×
Promoter holding
63.47%-0.01% QoQ
FII holding
7.62%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Ajanta Pharma Ltd

All →

Other promoter selling announcements

All →